Dendritic cell based genetic immunization stimulates potent tumor protection dependent on CD8 CTL cells in the absence of autoimmunity (Q80772528)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18299892%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Dendritic cell based genetic immunization stimulates potent tumor protection dependent on CD8 CTL cells in the absence of autoimmunity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18299892%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Sheng Zhang

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18299892%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Weiyi Huang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18299892%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

26 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18299892%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cancer Research and Clinical Oncology

3 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18299892%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18299892%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18299892%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

987-994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18299892%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00432-008-0368-4

3 January 2020

exact match

0 references

cites work

Peripheral CD8+ T cell tolerance against melanocytic self-antigens in the skin is regulated in two steps by CD4+ T cells and local inflammation: implications for the pathophysiology of vitiligo.

1 reference

12 December 2020

Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skin

1 reference

12 December 2020

Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens

1 reference

12 December 2020

The CD8+ T cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunity.

1 reference

12 December 2020

Elevated Frequencies of Self-reactive CD8+ T Cells following Immunization with a Xenoantigen Are Due to the Presence of a Heteroclitic CD4+ T-Cell Helper Epitope

1 reference

12 December 2020

Lymphocyte-hepatic stellate cell proximity suggests a direct interaction.

1 reference

12 December 2020

Redundant and alternative roles for activating Fc receptors and complement in an antibody-dependent model of autoimmune vitiligo

1 reference

12 December 2020

Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.

1 reference

12 December 2020

Anti-tumor T cell response and protective immunity in mice that received sublethal irradiation and immune reconstitution.

1 reference

12 December 2020

Genetically modified dendritic cells prime autoreactive T cells through a pathway independent of CD40L and interleukin 12: implications for cancer vaccines

1 reference

12 December 2020

Therapeutic effectiveness of recombinant cancer vaccines is associated with a prevalent T-cell receptor alpha usage by melanoma-specific CD8+ T lymphocytes.

1 reference

12 December 2020

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

1 reference

12 December 2020

Cutting edge: sustained expansion of CD8+ T cells requires CD154 expression by Th cells in acute graft versus host disease

1 reference

12 December 2020

Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity

1 reference

12 December 2020

Interdependency of MHC class II/self-peptide and CD1d/self-glycolipid presentation by TNF-matured dendritic cells for protection from autoimmunity

1 reference

12 December 2020

Tumor immunity and autoimmunity induced by immunization with homologous DNA

1 reference

12 December 2020

Optimization of a self antigen for presentation of multiple epitopes in cancer immunity

1 reference

12 December 2020

On the role of CD4+ T cells in the CD8+ T-cell response elicited by recombinant adenovirus vaccines

1 reference

12 December 2020

The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen

1 reference

12 December 2020

Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity

1 reference

12 December 2020

Enhanced antitumor immunity by murine cytokine activated T lymphocytes after cocultured with bone marrow derived dendritic cells pulsed with whole tumor lysates

1 reference

12 December 2020

Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease

1 reference

12 December 2020

Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo

1 reference

12 December 2020

Dendritic Cell-Derived IL-12 Is Not Required for the Generation of Cytotoxic, IFN- -Secreting, CD8+ CTL In Vivo

1 reference

12 December 2020

CTL-dependent and -independent antitumor immunity is determined by the tumor not the vaccine

1 reference

12 December 2020

Comparison of recombinant adenovirus and synthetic peptide for DC-based melanoma vaccination

1 reference

12 December 2020

Induction of circulating tumor-reactive CD8+ T cells after vaccination of melanoma patients with the gp100 209-2M peptide

1 reference

12 December 2020

Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts.

1 reference

12 December 2020

Coupling and uncoupling of tumor immunity and autoimmunity

1 reference

12 December 2020

10.1007/S00432-008-0368-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18299892%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference